Vasoactive intestinal peptide in rats with focal cerebral ischemia enhances angiogenesis

Neuroscience

Volumn 161, Issue 2, 2009, Pages 413-421

  Yang, J ^a   Zong, C H ^a   Zhao, Z H ^b   Hu, X D ^a   Shi, Q D ^a   Xiao, X L ^a   Liu, Y ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

angiogenesis; cerebral ischemia; rats; vascular endothelial growth factor; vasoactive intestinal peptide

Indexed keywords

BROXURIDINE; SEMAXANIB; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; MALE; MICROVASCULATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE;

ANIMALS; BRAIN; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; ISCHEMIC ATTACK, TRANSIENT; MALE; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASOACTIVE INTESTINAL PEPTIDE;

EID: 67349151280     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.03.052     Document Type: Article

References (33)

1. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., and Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17 (1986) 472-476
2. Bowman P.D., Bois M., Dorovini-Zis K., and Shivers R.R. Microvascular endothelial cells from brain. In: Piper H.M. (Ed). Cell culture techniques in heart and vessel research (1990), Springer-Verlag, Berlin 140-157
3. Carson M.P., and Haudenschild C.C. Microvascular endothelium and pericytes: high yield, low passage cultures. In Vitro Cell Dev Biol 22 (1986) 344-354
4. 2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells. Lung Cancer 31 (2001) 203-212
5. Collado B., Gutiérrez-Cañas I., Rodríguez-Henche N., Prieto J.C., and Carmena M.J. Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells. Regul Pept 119 (2004) 69-75
6. Collado B., Sánchez-Chapado M., Prieto J.C., and Carmena M.J. Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells. Mol Cell Endocrinol 249 (2006) 116-122
7. Collado B., Carmena M.J., Clemente C., Prieto J.C., and Bajo A.M. Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model. Peptides 28 (2007) 1896-1901
8. Cramer S.C., Nelles G., Benson R.R., Kaplan J.D., Parker R.A., Kwong K.K., Kennedy D.N., Finklestein S.P., and Rosen B.R. A functional MRI study of subjects recovered from hemiparetic stroke. Stroke 28 (1997) 2518-2527
9. Donovan E.A., and Kummar S. Targeting VEGF in cancer therapy. Curr Probl Cancer 30 (2006) 7-32
10. Fahrenkrug J., and Said S.I. VIP, PACAP, glucagons, and related peptides. Ann N Y Acad Sci 921 (2000) 1-110
11. Ferrara N., Gerber H.P., and Le Couter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
12. Gale N.W., and Yancopoulos G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13 (1999) 1055-1066
13. Gille H., Kowalski J., Li B., Le Couter J., Moffat B., Zioncheck T.F., Pelletier N., and Ferrara N. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 276 (2001) 3222-3230
14. Gould E., and Gross C.G. Neurogenesis in adult mammals: some progress and problems. J Neurosci 22 (2002) 619-623
15. Hayashi T., Noshita N., Sugawara T., and Chan P.H. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab 23 (2003) 166-180
16. Hoeben A., Landuyt B., Highley M.S., Wildiers H., Van Oosterom A.T., and De Bruijn E.A. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56 (2004) 549-580
17. Hu D., Hiley C.R., and Fan T.P. Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model. Br J Pharmacol 117 (1996) 545-551
18. Jiang Q., Zhang Z.G., Ding G.L., Zhang L., Ewing J.R., Wang L., Zhang R., Li L., Lu M., Meng H., Arbab A.S., Hu J., Li Q.J., Pourabdollah, Nejad D.S., Athiraman H., and Chopp M. Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI. Neuroimage 28 (2005) 698-707
19. Joo K.M., Chung Y.H., Kim M.K., Nam R.H., Lee B.L., Lee K.H., and Cha C.I. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J Comp Neurol 476 (2004) 388-413
20. Krupinski J., Kaluza J., Kumar P., Kumar S., and Wang J.M. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25 (1994) 1794-1798
21. Lange D., Funa K., Ishisaki A., Bauer R., and Wollina U. Autocrine endothelial regulation in brain stem vessels of newborn piglets. Histol Histopathol 14 (1999) 821-825
22. Lennmyr F., Ahmad K., Funa K., Olsson Y., and Terént A. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol 57 (1998) 874-882
23. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
24. Marti H.H., and Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A 95 (1998) 15809-15814
25. Marti H.J., Bernaudin M., Bellail A., Schoch H., Euler M., Petit E., and Risau W. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156 (2000) 965-976
26. Memezawa H., Minamisawa H., Smith M.L., and Siesjö B.K. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res 89 (1992) 67-78
27. Moody T.W., Hill J.M., and Jensen R.T. VIP as a trophic factor in the CNS and cancer cells. Peptides 24 (2003) 163-177
28. Pettersson A., Nagy J.A., Brown L.F., Sundberg C., Morgan E., Jungles S., Carter R., Krieger J.E., Manseau E.J., Harvey V.S., Eckelhoefer I.A., Feng D., Dvorak A.M., Mulligan R.C., and Dvorak H.F. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 80 (2000) 99-115
29. Ribatti D., Conconi M.T., and Nussdorfer G.G. Nonclassic endogenous novel [corrected] regulators of angiogenesis. Pharmacol Rev 59 (2007) 185-205
30. Voice J.K., Dorsam G., Chan R.C., Grinninger C., Kong Y., and Goetzl E.J. Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide. Regul Pept 109 (2002) 199-208
31. Zadeh G., and Guha A. Angiogenesis in nervous system disorders. Neurosurgery 539 (2003) 1362-1374
32. Zhang L., Zhang R.L., Wang Y., Zhang C.L., Zhang Z.G., Meng H., and Chopp M. Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor. Stroke 36 (2005) 847-852
33. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., and Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106 (2000) 829-838